Evaluation of the severity of chronic hepatitis C with 3-T 1H-MR spectroscopy

American Journal of Roentgenology

Volumn 190, Issue 5, 2008, Pages 1331-1339

  Orlacchio, Antonio ^a   Bolacchi, Francesca ^a   Cadioli, Marcello ^b   Bergamini, Alberto ^a   Cozzolino, Valeria ^a   Angelico, Mario ^a   Simonetti, Giovanni ^a  

^a TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^b PHILIPS HEALTHCARE   (United States)

Author keywords

1H MR spectroscopy; Chronic hepatitis; Liver fibrosis; Liver steatosis

Indexed keywords

CHOLINE; GLUTAMIC ACID; GLUTAMINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FATTY LIVER; FEMALE; HEPATITIS C; HISTOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CELL; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SCORING SYSTEM; SPECTROSCOPY; STEATOSIS; UNIVARIATE ANALYSIS;

ADULT; AGED; CHOLINE; FATTY LIVER; FEMALE; GLUTAMIC ACID; GLUTAMINE; HEPATITIS C, CHRONIC; HUMANS; LIPID METABOLISM; LIVER CIRRHOSIS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 43649105131     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.07.2262     Document Type: Article

References (42)

1. Pal S, Shuhart MC, Thomassen L, et al. Intrahepatic hepatitis C virus replication correlates with chronic hepatitis C disease severity in vivo. J Virol 2006; 80:2280-2290
2. Ngo Y, Munteanu M, Messous D, et al. A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C. Clin Chem 2006; 52:1887-1896
3. Colletta C, Smirne C, Fabris C, et al. Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal amino-transferases. Hepatology 2005; 42:838-845
4. McGill DB, Rakela J, Zinsmeister AR, Ott BJ. A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology 1990; 9:1396-1400
5. Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. Hepatology 2000; 32:477-481
6. Poynard T, Ratziu V, Bedossa P. Appropriateness of liver biopsy. Can J Gastroenterol 2000; 14:543-548
7. Ratziu V, Charlotte F, Heurtier A, et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005; 128:1898-1906
8. Younossi ZM, Gramlich T, Liu YC, et al. Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations. Mod Pathol 1998; 11:560-565
9. Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41:1313-1321
10. 31P MR spectroscopy to histology in chronic hepatitis C. Hepatology 2003; 37:788-794
11. Angus PW, Dixon RM, Rajagopalan B, et al. A study of patients with alcoholic liver disease by 31P magnetic resonance spectroscopy. Clin Sci 1990; 78:33-38
12. 31P MR spectroscopy. World J Gastroenterol 2005; 11:6926-6931
13. Adinolfi LE, Gambardella M, Andreana A, Tripodi MF, Utili R, Ruggiero G. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 2001; 33:1358-1364
14. Clouston AD, Jonsson JR, Purdie DM, et al. Steatosis and chronic hepatitis C: analysis of fibrosis and stellate cell activation. J Hepatol 2001; 34:314-320
15. Hourigan LF, Macdonald GA, Purdie D, et al. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology 1999; 29:1215-1219
16. Serfaty L, Poujol-Robert A, Carbonell N, Chazouilleres O, Poupon RE, Poupon R. Effect of the interaction between steatosis and alcohol intake on liver fibrosis progression in chronic hepatitis. Am J Gastroenterol 2002; 97:1807-1812
17. Castéra L, Hézode C, Roudot-Thoraval F, et al. Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies. Gut 2003; 52:288-292
18. Longo R, Ricci C, Masutti F, et al. Fatty infiltration of the liver quantification by 1H localized magnetic resonance spectroscopy and comparison with computed tomography. Invest Radiol 1993; 28:297-302
19. Thomsen C, Becker U, Winkler K, Christoffersen P, Jensen M, Henriksen O. Quantification of liver fat using magnetic resonance spectroscopy. Magn Reson Imaging 1994; 12:487-495
20. Cho SG, Kim MY, Kim HJ, et al. Chronic hepatitis: in vivo proton MR spectroscopic evaluation of the liver and correlation with histopathologic findings. Radiology 2001; 221:740-746
21. Simmonds P, Alberti A, Alter HJ, et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994; 19:1321-1324
22. [No authors listed]. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology 1994; 20:15-20
23. [No authors listed]. Which classification for chronic hepatitis? Lessons from the hepatitis C virus [in French]. Gastroenterol Clin Biol 1994; 18:403-406
24. Bell JD, Cox IJ, Sargentoni J, et al. A 31P and 1H-NMR investigation in vitro of normal and abnormal human liver. Biochim Biophys Acta 1993; 1225:71-77
25. Cortez-Pinto H, Chatham J, Chacko VP, Arnold C, Rashid A, Diehl AM. Alteration in liver homeostasis in human non-alcoholic steatohepatitis: a pilot study. JAMA 1999; 282:1659-1664
26. Chang JS, Taouli B, Salibi N, Hecht EM, Chin DG, Lee VS. Opposed-phase MRI for fat quantification in fat-water phantoms with 1H MR spectroscopy to resolve ambiguity of fat or water dominance. AJR 2006; 187:103-106
27. Tarasów E, Siergiejczyk L, Panasiuk A, et al. MR proton spectroscopy in liver examinations of healthy individuals in vivo. Med Sci Monit 2002; 8:MT36-MT40
28. Duarte I, Stanley EG, Holmes E, et al. Metabolic assessment of human liver transplants from biopsy samples at the donor and recipient stages using high-resolution magic angle spinning 1H NMR spectroscopy. Anal Chem 2005; 77:5570-5578
29. Bach N, Thung SN, Schaffner F. The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis. Hepatology 1992; 15:572-577
30. Fischer HP, Willsch E, Bierhoff E, Pfeifer U. Histopathologic findings in chronic hepatitis C. J Hepatol 1996; 24:35-42
31. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Host- and disease-specific factors affecting steatosis in chronic hepatitis C. J Hepatol 1998; 29:198-206
32. Barba G, Harper F, Harada T, et al. Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc Natl Acad Sci U S A 1997; 94:1200-1205
33. Moriya K, Yotsuyanagi H, Shintani Y, et al. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. J Gen Virol 1997; 78:1527-1531
34. Sharma P, Balan V, Hernandez J, et al. Hepatic steatosis in hepatitis C virus genotype 3 infection: does it correlate with body mass index, fibrosis, and HCV risk factors? Dig Dis Sci 2004; 49:25-29
35. Lee RG. Nonalcoholic steatohepatitis: a study of 49 patients. Hum Pathol 1989; 20:594-599
36. Powell EE, Cooksley GE, Hanson R, Searle J, Halliday RW, Powell LW. The natural history of non-alcoholic steatohepatitis: a follow-up study of 42 patients followed for up to 21 years. Hepatology 1990; 11:74-80
37. Okolo PI, Diehl AM. Nonalcoholic steatohepatitis and local fatty liver. In: Feldman M, Scharschmidt BF, Sleisenger MH, eds. Sleisenger and Fordtran's gastrointestinal and liver disease, 6th ed. Philadelphia, PA: Saunders, 1988:1215-1220
38. Ochiai H, Higa K, Hishiama N, Hisamatsu S, Fujise H. Characterization of several amino acids transport and glutamine metabolism in MOLT4 human T4 leukemia cells. Clin Lab Haematol 2006; 28:399-404
39. Michel V, Yuan Z, Ramsubir S, Bakovic M. Choline transport for phospholipid synthesis. Exp Biol Med 2006; 231:490-504
40. François C, Decaestecker C, Petein M, et al. Classification strategies for the grading of renal cell carcinomas, based on nuclear morphometry and densitometry. J Pathol 1999; 183:141-150
41. Preul MC, Caramanos Z, Leblanc R, Villemure JG, Arnold DL. Using pattern analysis of in vivo proton MRSI data to improve the diagnosis and surgical management of patients with brain tumors. NMR Biomed 1998; 11:192-200
42. Siddique I, El-Naga HA, Madda JP, Memon A, Hasan F. Sampling variability on percutaneous liver biopsy in patients virus infection. Scand J Gastroenterol 2003; 38:427-432